Jasper Hellweg
Stock Analyst at Argus Research
(4.08)
# 1,602
Out of 4,421 analysts
230
Total ratings
55.5%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GSK GSK plc | Maintained: Buy | n/a | $50.67 | - | 2 | Jun 8, 2026 | |
| NVS Novartis AG | Rated: Buy | $180 → $160 | $147.08 | +8.78% | 2 | Jun 4, 2026 | |
| ZTS Zoetis | Downgraded: Hold | n/a | $78.71 | - | 12 | May 26, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $220 → $250 | $216.49 | +15.48% | 5 | May 13, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $130 | $113.87 | +14.17% | 5 | May 8, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Buy | $55 | $49.74 | +10.57% | 3 | Apr 6, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | n/a | $43.19 | - | 7 | Mar 20, 2026 | |
| UTHR United Therapeutics | Rated: Buy | $345 → $560 | $536.59 | +4.36% | 11 | Mar 3, 2026 | |
| MRNA Moderna | Reiterated: Hold | n/a | $63.96 | - | 14 | Jan 13, 2026 | |
| BIIB Biogen | Maintained: Hold | n/a | $196.58 | - | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $54.00 | - | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 | $24.22 | +3.22% | 6 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 79.85 → CHF 67.87 | $51.90 | +30.77% | 4 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $609.94 | - | 13 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $123.76 | n/a | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $100 | $161.93 | n/a | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $19.89 | n/a | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $31.48 | n/a | 9 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,098.57 | n/a | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.37 | n/a | 4 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $360 | $337.60 | n/a | 6 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $60 | $42.38 | n/a | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $465 → $550 | $451.63 | n/a | 11 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $125 | $90.96 | n/a | 8 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $70 | $98.22 | n/a | 6 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 | $4.80 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $285 → $225 | $153.93 | n/a | 6 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $255.82 | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $165 | $195.00 | n/a | 6 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $475 → $500 | $388.50 | n/a | 5 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $290 | $167.77 | n/a | 5 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 → $275 | $375.17 | n/a | 6 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $50 | $45.29 | n/a | 3 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.00 | n/a | 5 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $135 | $102.41 | n/a | 5 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $115 | $47.86 | n/a | 4 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.25 | n/a | 3 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $274.88 | n/a | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $33.55 | n/a | 1 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $20.27 | n/a | 2 | Aug 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $257.70 | n/a | 1 | Aug 31, 2016 |
GSK plc
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $50.67
Upside: -
Novartis AG
Jun 4, 2026
Rated: Buy
Price Target: $180 → $160
Current: $147.08
Upside: +8.78%
Zoetis
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $78.71
Upside: -
AbbVie
May 13, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $216.49
Upside: +15.48%
Merck & Co.
May 8, 2026
Reiterated: Buy
Price Target: $130
Current: $113.87
Upside: +14.17%
Roche Holding AG
Apr 6, 2026
Upgraded: Buy
Price Target: $55
Current: $49.74
Upside: +10.57%
Novo Nordisk
Mar 20, 2026
Maintained: Hold
Price Target: n/a
Current: $43.19
Upside: -
United Therapeutics
Mar 3, 2026
Rated: Buy
Price Target: $345 → $560
Current: $536.59
Upside: +4.36%
Moderna
Jan 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $63.96
Upside: -
Biogen
Jan 9, 2026
Maintained: Hold
Price Target: n/a
Current: $196.58
Upside: -
Jan 7, 2026
Maintained: Hold
Price Target: n/a
Current: $54.00
Upside: -
Nov 19, 2025
Upgraded: Buy
Price Target: $25
Current: $24.22
Upside: +3.22%
Oct 10, 2025
Maintained: Buy
Price Target: CHF 79.85 → CHF 67.87
Current: $51.90
Upside: +30.77%
Jun 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $609.94
Upside: -
May 5, 2025
Reiterated: Buy
Price Target: $100 → $120
Current: $123.76
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $150 → $100
Current: $161.93
Upside: n/a
Feb 24, 2025
Upgraded: Buy
Price Target: $40
Current: $19.89
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: $20
Current: $31.48
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: n/a
Current: $1,098.57
Upside: n/a
Jan 6, 2025
Maintained: Hold
Price Target: n/a
Current: $15.37
Upside: n/a
Aug 20, 2024
Maintained: Buy
Price Target: $340 → $360
Current: $337.60
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $55 → $60
Current: $42.38
Upside: n/a
Jun 17, 2024
Maintained: Buy
Price Target: $465 → $550
Current: $451.63
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $105 → $125
Current: $90.96
Upside: n/a
Apr 25, 2024
Maintained: Buy
Price Target: $90 → $70
Current: $98.22
Upside: n/a
Dec 7, 2022
Upgraded: Buy
Price Target: $26
Current: $4.80
Upside: n/a
Oct 24, 2022
Maintained: Buy
Price Target: $285 → $225
Current: $153.93
Upside: n/a
Sep 19, 2022
Downgraded: Hold
Price Target: n/a
Current: $255.82
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $135 → $165
Current: $195.00
Upside: n/a
Feb 7, 2022
Maintained: Buy
Price Target: $475 → $500
Current: $388.50
Upside: n/a
Sep 10, 2021
Maintained: Buy
Price Target: $260 → $290
Current: $167.77
Upside: n/a
Aug 2, 2021
Maintained: Buy
Price Target: $195 → $275
Current: $375.17
Upside: n/a
Jun 7, 2021
Maintained: Buy
Price Target: $43 → $50
Current: $45.29
Upside: n/a
May 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $8.00
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $95 → $135
Current: $102.41
Upside: n/a
Jun 12, 2020
Maintained: Buy
Price Target: $135 → $115
Current: $47.86
Upside: n/a
Apr 17, 2020
Downgraded: Hold
Price Target: n/a
Current: $10.25
Upside: n/a
Mar 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $274.88
Upside: n/a
Oct 30, 2019
Downgraded: Hold
Price Target: n/a
Current: $33.55
Upside: n/a
Aug 15, 2019
Upgraded: Buy
Price Target: $40
Current: $20.27
Upside: n/a
Aug 31, 2016
Downgraded: Hold
Price Target: n/a
Current: $257.70
Upside: n/a